President & Chief Executive Officer at Recor Medical
📍 Palo Alto, California, United States
Lara Barghout is the President and CEO of Recor Medical, leveraging over 20 years of experience in the medical device industry. She leads the global commercialization of innovative therapies for hypertension and holds an MBA from the University of Michigans Stephen M. Ross School of Business.
A passionate and people-focused leader, Lara is a life-long champion for diversity, equity, and inclusion. Throughout her career, she has actively sponsored and chaired womens leadership networks at major corporations, demonstrating a clear commitment to advancing women in the industry.
She recently led Recor Medical in securing the first FDA approval for a renal denervation system to treat hypertension.
Read the full overview →
Experience
17 Years
Current Role
President & Chief Executive Officer
Job Level
Leadership
Location
Palo Alto, California, United States
Personality Overview
How Lara shows up
Objective Thinker
Slow Buyer
Fact-Driven
They are thorough and always follow a systematic approach. They are heavily focused on quality and prefer doing things the right way, even if it takes time. They do not like taking risks at all and go for proven options in the end.
Priorities
Topics Lara cares about
Renal Denervation
She is leading the global commercialization of Recor's Paradise uRDN system, a novel ultrasound-based therapy for hypertension that recently gained FDA, CMS, and Japan approvals.
Hypertension Treatment
Frequently speaks on providing new, non-drug options for patients suffering from uncontrolled hypertension, aiming to improve health outcomes and quality of life.
+5 more topicsLogin to view topics
Career
Work history
1-2023
President & Chief Executive Officer
Recor Medical
12-2018 - 12-2022
Senior Vice President - Head of Advanced Therapies NAM
Siemens Healthineers
12-2018 - 12-2022
Executive Sponsor, Women’s Impact Network
Siemens Healthineers
1-2017 - 12-2018
Senior Vice President, Global Commercial Operations
Terumo Cardiovascular
1-2014 - 12-2018
Chair, Women’s Initiative Network
Terumo Cardiovascular
In the press
Media appearances
ReCor Medical Names Lara Barghout as President and Chief Executive Officer. Featured in EV Today
Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.
Other Recor Medical Employees
Explore more public profiles from related professionals.